4//SEC Filing
Thornton Michael Milos 4
Accession 0001209191-21-025846
CIK 0001681682other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:08 PM ET
Size
9.8 KB
Accession
0001209191-21-025846
Insider Transaction Report
Form 4
Thornton Michael Milos
Chief Technology Officer
Transactions
- Award
Stock Options
2021-04-05+50,000→ 50,000 totalExercise: $2.64Exp: 2031-04-05→ Common Stock (50,000 underlying) - Sale
Common Stock
2021-03-29$2.37/sh−18,750$44,438→ 274,960 total - Sale
Common Stock
2021-04-07$2.53/sh−15,000$37,950→ 259,960 total
Footnotes (4)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.35 to $2.39, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.56, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F4]This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001706297
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:08 PM ET
- Size
- 9.8 KB